Over the Counter (OTC) Analgesics Market, By Type of Drug (Acetaminophen, Nonsteroidal Anti- inflammatory Drug (NSAIDs), Salicylates, and Other Analgesics), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others Distribution Channels), and By Geography (North America, Europe, Asia-Pacific, South America, and Middle East and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
Analgesics are medicines that are used to relieve pain. They are also known as painkillers or pain relievers. These are a class of medicines designed specifically to relieve pain. They include several classes of drugs (such as non-steroidal anti-inflammatory drugs, acetaminophen, antiepileptics, antidepressants, opioids, and local anesthetics).
Market Dynamics:
Rise in prevalence chronic diseases, increase in adoption of OTC analgesics or rise in consumption of OTC analgesics, rise in geriatric population, and rise in demand for narcotics analgesic drugs are major factors expected to drive growth of the global over the counter (OTC) analgesics market.
For instance, in December 2021, Heron Therapeutics, Inc. announced that the U.S. Food & Drug Administration (FDA) approved its supplemental New Drug Application (sNDA) for ZYNRELEF (bupivacaine and meloxicam) extended-release solution to significantly expand the indication.
Moreover, in July 2021, Heron Therapeutics announced the commercial launch and availability of ZYNRELEF in the U.S. for the management of postoperative pain for up to 72 hours.
Key features of the study:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook